Company News

Ocean Optics appoints new president Kevin Chittim takes helm at photonics manufacturer Spectroscopy veteran joins Shimadzu UK Robert Keighley will drive sales at instrumentation firm Pierre Delavaud joins SkyePharma from Catalent Takes on role of executive vp of sales and business development Former Lilly executive joins AMRI Charles Jensen is appointed as DMPK director Scil Proteins appoints chief scientific officer Ulrich Haupts joins the biotech firm from Bayer Healthcare Immunovaccine hires John Trizzino as ceo Vaccine specialist brings 25 years of experience to the role Bachem makes management changes To take effect in April 2012 GSK celebrates its scientific contribution to 2012 Olympics UK pharma giant will operate anti-doping laboratory during the London Olympics Delenex completes its management team Thomas Jung becomes chief medical officer Ardelyx appoints Mark Kaufmann as chief business officer Role includes business development, licensing and strategic planning Quintiles appoints global head of Phase I division CMSO Oren Cohen takes the role Helen Torley joins Onyx Pharmaceuticals Takes the position of executive vp and chief commercial officer Peter Gough wins Leveraging/Collaboration Award For helping to develop risk-based approaches to pharma quality Yourway Transport appoints head of BioPharma Services business Tim Brewer becomes president IP specialist Mathys & Squire expands Appoints Dr David Martin at Manchester office Whitehouse Scientific appoints senior scientist Keith Brocklehurst brings additional analytical expertise to the UK firm

Trending Articles

  1. New Managing Director for Shimadzu Europa Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
  2. BioDuro appoints Greg Makara to lead discovery chemistry BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
  3. EyeC expands OEM growth with new business development manager Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
  4. Three new commercial appointments for Symbiosis Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
  5. Lonza nominates Pearl Huang to board Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation